SII seeks permission for phase-3 study of Covid vaccine Covovax as booster dose in adults

Covovax is manufactured by technology transfer from Novavax and is approved by the European Medicines Agency for conditional marketing authorisation and also granted emergency use listing by WHO.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/RwFrC0H
via IFTTT